| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | positive regulation of synaptic vesicle priming | 1.76e-05 | 2 | 87 | 2 | GO:0010808 | |
| GeneOntologyCellularComponent | cell cortex | UNC13B ZHX3 SHROOM3 PDE4DIP MYRIP ARC FMN2 MACF1 RIMS1 TRIP10 ARHGAP33 | 3.98e-07 | 371 | 87 | 11 | GO:0005938 |
| MousePheno | abnormal laryngeal cartilage morphology | 1.47e-05 | 29 | 73 | 4 | MP:0002256 | |
| Domain | SH3 | 5.77e-06 | 216 | 84 | 8 | PS50002 | |
| Domain | SH3_domain | 6.60e-06 | 220 | 84 | 8 | IPR001452 | |
| Domain | SH3 | 5.35e-05 | 216 | 84 | 7 | SM00326 | |
| Domain | Spectrin/alpha-actinin | 3.96e-04 | 32 | 84 | 3 | IPR018159 | |
| Domain | SPEC | 3.96e-04 | 32 | 84 | 3 | SM00150 | |
| Domain | Homeodomain-like | 7.39e-04 | 332 | 84 | 7 | IPR009057 | |
| Domain | SH3_1 | 8.67e-04 | 164 | 84 | 5 | PF00018 | |
| Domain | FYVE_2 | 1.07e-03 | 11 | 84 | 2 | PF02318 | |
| Domain | RABBD | 1.28e-03 | 12 | 84 | 2 | PS50916 | |
| Domain | Rab_BD | 1.28e-03 | 12 | 84 | 2 | IPR010911 | |
| Domain | PDZ | 3.77e-03 | 141 | 84 | 4 | PF00595 | |
| Domain | HOMEOBOX_1 | 4.24e-03 | 236 | 84 | 5 | PS00027 | |
| Domain | HOX | 4.32e-03 | 237 | 84 | 5 | SM00389 | |
| Domain | EPHD | 4.36e-03 | 22 | 84 | 2 | PS51805 | |
| Domain | Znf_FYVE_PHD | 4.37e-03 | 147 | 84 | 4 | IPR011011 | |
| Domain | PDZ | 4.47e-03 | 148 | 84 | 4 | SM00228 | |
| Domain | HOMEOBOX_2 | 4.47e-03 | 239 | 84 | 5 | PS50071 | |
| Domain | Homeobox_dom | 4.47e-03 | 239 | 84 | 5 | IPR001356 | |
| Domain | - | 4.69e-03 | 150 | 84 | 4 | 2.30.42.10 | |
| Domain | Spectrin | 4.76e-03 | 23 | 84 | 2 | PF00435 | |
| Domain | PDZ | 4.80e-03 | 151 | 84 | 4 | PS50106 | |
| Domain | PDZ | 4.91e-03 | 152 | 84 | 4 | IPR001478 | |
| Domain | ANTENNAPEDIA | 5.17e-03 | 24 | 84 | 2 | PS00032 | |
| Domain | SR | 5.61e-03 | 25 | 84 | 2 | SM00202 | |
| Domain | - | 5.61e-03 | 25 | 84 | 2 | 3.10.250.10 | |
| Pubmed | CCDC88C SHROOM3 MIA3 TRIO FARP1 SRC PDE4DIP EIF4G1 HECTD4 ARC DNM1L MACF1 DIDO1 ZNF318 RIMS1 PRRC2A WNK2 RAI1 | 3.74e-11 | 963 | 89 | 18 | 28671696 | |
| Pubmed | TUBGCP6 ZNF469 TCF12 C1orf226 COQ8A SUPT7L FMN2 HRES1 RNF213 MACF1 ZNF318 RERE INO80 SAP130 GGCX ARHGAP33 RAI1 | 3.10e-09 | 1116 | 89 | 17 | 31753913 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | UNC13B CCDC88C SHROOM3 EHBP1L1 KMT2D TRIO TMEM158 EIF4G1 HECTD4 NINL ARC INO80 GGA1 WNK2 ARHGAP33 RAI1 | 1.94e-08 | 1105 | 89 | 16 | 35748872 |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | UNC13B POLDIP3 SRC EIF4G1 TJP2 MACF1 DIDO1 PRRC2A GGCX PNMA8B | 3.15e-08 | 361 | 89 | 10 | 26167880 |
| Pubmed | Inhibition of Drp1 SUMOylation by ALR protects the liver from ischemia-reperfusion injury. | 6.47e-08 | 4 | 89 | 3 | 33110216 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | TUBGCP6 ZHX3 KMT2D EIF4G1 NUP98 DAB2 TJP2 DIDO1 ZNF318 RIMS1 RERE PRRC2A MPG | 8.83e-08 | 774 | 89 | 13 | 15302935 |
| Pubmed | HOXA5 ZHX3 KMT2D TCF12 POLDIP3 SUPT7L EIF4G1 NUP98 PPP1R13B NCOA1 DIDO1 ZNF318 RERE INO80 SAP130 SOX13 PRRC2A | 1.13e-07 | 1429 | 89 | 17 | 35140242 | |
| Pubmed | AKAP6 TUBGCP6 SHROOM3 MAST4 COQ8A HECTD4 NINL DIDO1 INO80 WNK2 RAI1 | 1.14e-07 | 529 | 89 | 11 | 14621295 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | PTPDC1 SHROOM3 MIA3 TRIO COQ8A FARP1 SRC HECTD4 MYRIP RNF213 MACF1 ANKRD12 RIMS1 RERE SAP130 WNK2 RAI1 | 2.03e-07 | 1489 | 89 | 17 | 28611215 |
| Pubmed | AKAP6 MIA3 SALL3 COQ8A FARP1 TJP2 FMN2 DNM1L MACF1 DIDO1 ZNF318 ANKRD12 INO80 WDFY4 | 6.52e-07 | 1084 | 89 | 14 | 11544199 | |
| Pubmed | 1.35e-06 | 9 | 89 | 3 | 15184363 | ||
| Pubmed | 2.62e-06 | 151 | 89 | 6 | 17043677 | ||
| Pubmed | KMT2D MAST4 PDE4DIP EIF4G1 DAB2 PPP1R13B MACF1 GGA1 SAP130 SOX13 | 2.84e-06 | 591 | 89 | 10 | 15231748 | |
| Pubmed | 4.15e-06 | 360 | 89 | 8 | 33111431 | ||
| Pubmed | 6.00e-06 | 268 | 89 | 7 | 33640491 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 20147447 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 22660634 | ||
| Pubmed | A novel Gfer-Drp1 link in preserving mitochondrial dynamics and function in pluripotent stem cells. | 6.48e-06 | 2 | 89 | 2 | 20581476 | |
| Pubmed | Munc13-1 is required for presynaptic long-term potentiation. | 6.48e-06 | 2 | 89 | 2 | 21849565 | |
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 28646508 | ||
| Pubmed | RIM1alpha forms a protein scaffold for regulating neurotransmitter release at the active zone. | 6.48e-06 | 2 | 89 | 2 | 11797009 | |
| Pubmed | POLDIP3 EIF4G1 NUP98 TJP2 MACF1 DIDO1 ZNF318 PRRC2A AQR RAI1 | 6.82e-06 | 653 | 89 | 10 | 22586326 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | CCDC88C FAM184A SHROOM3 MIA3 MAST4 TRIO FARP1 NINL TJP2 PPP1R13B GGA1 | 1.16e-05 | 853 | 89 | 11 | 28718761 |
| Pubmed | A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. | 1.19e-05 | 298 | 89 | 7 | 32353859 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | CCDC88C SHROOM3 MAST4 TRIO EIF4G1 TJP2 FMN2 NHS DNM1L MACF1 AQR | 1.27e-05 | 861 | 89 | 11 | 36931259 |
| Pubmed | PTPDC1 MIA3 KMT2D C1orf226 TRIO FARP1 NUP98 PPP1R13B FMN2 RNF213 NHS PRRC2A | 1.49e-05 | 1049 | 89 | 12 | 27880917 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 1.51e-05 | 430 | 89 | 8 | 35044719 | |
| Pubmed | 1.68e-05 | 209 | 89 | 6 | 36779422 | ||
| Pubmed | 1.94e-05 | 3 | 89 | 2 | 9786846 | ||
| Pubmed | Ligand-dependent degradation of SRC-1 is pivotal for progesterone receptor transcriptional activity. | 1.94e-05 | 3 | 89 | 2 | 21273440 | |
| Pubmed | 1.94e-05 | 3 | 89 | 2 | 16704978 | ||
| Pubmed | 1.94e-05 | 3 | 89 | 2 | 15330860 | ||
| Pubmed | MACF1 promotes osteoblast differentiation by sequestering repressors in cytoplasm. | 1.94e-05 | 3 | 89 | 2 | 33664480 | |
| Pubmed | 1.94e-05 | 3 | 89 | 2 | 17627277 | ||
| Pubmed | 1.94e-05 | 3 | 89 | 2 | 12163476 | ||
| Pubmed | Functional interaction of the active zone proteins Munc13-1 and RIM1 in synaptic vesicle priming. | 1.94e-05 | 3 | 89 | 2 | 11343654 | |
| Pubmed | 1.94e-05 | 3 | 89 | 2 | 28673385 | ||
| Pubmed | A census of human transcription factors: function, expression and evolution. | HOXA5 HOXB1 ZHX3 KMT2D TCF12 ZNF197 NCOA1 TSHZ1 RERE SIX1 SOX13 | 2.07e-05 | 908 | 89 | 11 | 19274049 |
| Pubmed | 2.64e-05 | 608 | 89 | 9 | 16713569 | ||
| Pubmed | 2.93e-05 | 472 | 89 | 8 | 38943005 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 3.41e-05 | 351 | 89 | 7 | 38297188 | |
| Pubmed | 3.60e-05 | 486 | 89 | 8 | 20936779 | ||
| Pubmed | 3.83e-05 | 638 | 89 | 9 | 31182584 | ||
| Pubmed | Transient, phorbol ester-induced DOC2-Munc13 interactions in vivo. | 3.87e-05 | 4 | 89 | 2 | 10488064 | |
| Pubmed | 3.87e-05 | 4 | 89 | 2 | 22328528 | ||
| Pubmed | 3.87e-05 | 4 | 89 | 2 | 12473651 | ||
| Pubmed | RIM proteins activate vesicle priming by reversing autoinhibitory homodimerization of Munc13. | 3.87e-05 | 4 | 89 | 2 | 21262469 | |
| Pubmed | 3.87e-05 | 4 | 89 | 2 | 24036110 | ||
| Pubmed | 3.87e-05 | 4 | 89 | 2 | 12456510 | ||
| Pubmed | 3.87e-05 | 4 | 89 | 2 | 27430721 | ||
| Pubmed | The steroid receptor co-activator-1 (SRC-1) potentiates TGF-beta/Smad signaling: role of p300/CBP. | 3.87e-05 | 4 | 89 | 2 | 15688032 | |
| Pubmed | 4.22e-05 | 497 | 89 | 8 | 23414517 | ||
| Pubmed | An active vesicle priming machinery suppresses axon regeneration upon adult CNS injury. | 6.44e-05 | 5 | 89 | 2 | 34706221 | |
| Pubmed | 6.44e-05 | 5 | 89 | 2 | 18483622 | ||
| Pubmed | 6.44e-05 | 5 | 89 | 2 | 32755572 | ||
| Pubmed | 6.44e-05 | 5 | 89 | 2 | 22248876 | ||
| Pubmed | 6.44e-05 | 5 | 89 | 2 | 25049393 | ||
| Pubmed | Disentangling the Roles of RIM and Munc13 in Synaptic Vesicle Localization and Neurotransmission. | 6.44e-05 | 5 | 89 | 2 | 33139401 | |
| Pubmed | 6.44e-05 | 5 | 89 | 2 | 12072427 | ||
| Pubmed | 6.44e-05 | 5 | 89 | 2 | 7911971 | ||
| Pubmed | Restricted expression of homeobox genes distinguishes fetal from adult human smooth muscle cells. | 6.44e-05 | 5 | 89 | 2 | 8570656 | |
| Pubmed | ADCY4 TRIO FARP1 PDE4DIP EIF4G1 TJP2 DNM1L MACF1 BCAN RIMS1 PRRC2A WNK2 PNMA8B | 7.03e-05 | 1431 | 89 | 13 | 37142655 | |
| Pubmed | 8.62e-05 | 407 | 89 | 7 | 12693553 | ||
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 8.74e-05 | 281 | 89 | 6 | 28706196 | |
| Pubmed | The mouse segmentation gene kr encodes a novel basic domain-leucine zipper transcription factor. | 9.65e-05 | 6 | 89 | 2 | 8001130 | |
| Pubmed | 9.65e-05 | 6 | 89 | 2 | 12630920 | ||
| Pubmed | 9.65e-05 | 6 | 89 | 2 | 10777539 | ||
| Pubmed | 9.65e-05 | 6 | 89 | 2 | 19955471 | ||
| Pubmed | Degradation of HER2 by Cbl-based chimeric ubiquitin ligases. | 9.65e-05 | 6 | 89 | 2 | 17875712 | |
| Pubmed | Role of CBP in regulating HIF-1-mediated activation of transcription. | 9.65e-05 | 6 | 89 | 2 | 15615775 | |
| Pubmed | 9.65e-05 | 6 | 89 | 2 | 10973497 | ||
| Pubmed | 9.65e-05 | 6 | 89 | 2 | 10497212 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | EHBP1L1 POLDIP3 FARP1 EIF4G1 HECTD4 MACF1 DIDO1 INO80 AQR ARHGAP33 MPG | 1.00e-04 | 1082 | 89 | 11 | 38697112 |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | 1.03e-04 | 565 | 89 | 8 | 25468996 | |
| Pubmed | FAM184A SHROOM3 FARP1 SUPT7L EIF4G1 MACF1 DIDO1 ZNF318 INO80 PRRC2A AQR GGCX MPG | 1.10e-04 | 1497 | 89 | 13 | 31527615 | |
| Pubmed | Multiple epigenetic maintenance factors implicated by the loss of Mll2 in mouse development. | 1.35e-04 | 7 | 89 | 2 | 16540515 | |
| Pubmed | 1.35e-04 | 7 | 89 | 2 | 15788656 | ||
| Pubmed | Mutation of a nucleosome compaction region disrupts Polycomb-mediated axial patterning. | 1.35e-04 | 7 | 89 | 2 | 28280206 | |
| Pubmed | 1.35e-04 | 7 | 89 | 2 | 15695802 | ||
| Pubmed | Munc13 supports fusogenicity of non-docked vesicles at synapses with disrupted active zones. | 1.35e-04 | 7 | 89 | 2 | 36398873 | |
| Pubmed | 1.35e-04 | 101 | 89 | 4 | 26949739 | ||
| Pubmed | 1.52e-04 | 104 | 89 | 4 | 9205841 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | ZHX3 SALL3 POLDIP3 EIF4G1 NUP98 DIDO1 ZNF318 SAP130 PRRC2A RAI1 | 1.65e-04 | 954 | 89 | 10 | 36373674 |
| Pubmed | 1.71e-04 | 777 | 89 | 9 | 35844135 | ||
| Pubmed | Genetic analysis of coronary artery disease single-nucleotide polymorphisms in diabetic nephropathy. | 1.79e-04 | 8 | 89 | 2 | 19336575 | |
| Pubmed | Targeting of SWI/SNF chromatin remodelling complexes to estrogen-responsive genes. | 1.79e-04 | 8 | 89 | 2 | 12145209 | |
| Pubmed | 1.79e-04 | 8 | 89 | 2 | 27923061 | ||
| Pubmed | 1.79e-04 | 8 | 89 | 2 | 17923693 | ||
| Pubmed | Intersectin (ITSN) family of scaffolds function as molecular hubs in protein interaction networks. | 1.95e-04 | 111 | 89 | 4 | 22558309 | |
| Pubmed | 2.06e-04 | 329 | 89 | 6 | 17474147 | ||
| Pubmed | 2.42e-04 | 339 | 89 | 6 | 30415952 | ||
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 2.49e-04 | 341 | 89 | 6 | 32971831 | |
| Pubmed | HENA, heterogeneous network-based data set for Alzheimer's disease. | 2.62e-04 | 120 | 89 | 4 | 31413325 | |
| Pubmed | ZHX3 POLDIP3 EIF4G1 NUP98 RNF213 DNM1L DIDO1 INO80 SAP130 AQR | 2.69e-04 | 1014 | 89 | 10 | 32416067 | |
| Pubmed | 2.74e-04 | 347 | 89 | 6 | 17114649 | ||
| Pubmed | 2.88e-04 | 10 | 89 | 2 | 33773096 | ||
| Pubmed | 2.88e-04 | 10 | 89 | 2 | 15001550 | ||
| Pubmed | 3.15e-04 | 503 | 89 | 7 | 16964243 | ||
| Pubmed | 3.23e-04 | 847 | 89 | 9 | 35850772 | ||
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 3.26e-04 | 231 | 89 | 5 | 16452087 | |
| Interaction | YWHAH interactions | CCDC88C PTPDC1 SHROOM3 MAST4 TRIO SRC EIF4G1 HECTD4 NINL TJP2 FMN2 NCOA1 NHS DNM1L MACF1 RIMS1 WNK2 AQR | 1.05e-06 | 1102 | 88 | 18 | int:YWHAH |
| Interaction | MAPRE1 interactions | MAST4 TRIO SRC PDE4DIP EIF4G1 NUP98 DAB2 PPP1R13B MACF1 BCL3 PRRC2A | 1.45e-05 | 514 | 88 | 11 | int:MAPRE1 |
| Cytoband | Xp22.13 | 1.03e-04 | 8 | 89 | 2 | Xp22.13 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 1.07e-03 | 15 | 59 | 2 | 529 | |
| GeneFamily | PDZ domain containing | 1.53e-03 | 152 | 59 | 4 | 1220 | |
| Coexpression | LAKE_ADULT_KIDNEY_C4_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S2 | 1.43e-07 | 176 | 88 | 8 | M39223 | |
| Coexpression | MCCABE_HOXC6_TARGETS_CANCER_UP | 3.48e-06 | 31 | 88 | 4 | M15456 | |
| Coexpression | BROWNE_HCMV_INFECTION_20HR_DN | 2.45e-05 | 102 | 88 | 5 | M5601 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000 | UNC13B CCDC88C PTPDC1 FAM184A SHROOM3 KIAA1549L MFSD6 SRC NINL TJP2 FMN2 NCOA1 NHS MACF1 TSHZ1 WNK2 | 2.20e-06 | 986 | 87 | 16 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 3.06e-05 | 298 | 87 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000 | UNC13B CCDC88C SHROOM3 KIAA1549L MFSD6 NINL TJP2 FMN2 NCOA1 RNF213 NHS MACF1 BCL3 SIX1 | 4.42e-05 | 984 | 87 | 14 | Facebase_RNAseq_e10.5_Olfactory Pit_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#4 | 4.72e-05 | 232 | 87 | 7 | Facebase_RNAseq_e9.5_Maxillary Arch_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_500_k-means-cluster#4 | 5.17e-05 | 98 | 87 | 5 | Facebase_RNAseq_e10.5_Olfactory Pit_500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000_k-means-cluster#2 | 1.50e-04 | 279 | 87 | 7 | Facebase_RNAseq_e10.5_Olfactory Pit_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#2 | BOC PTPDC1 HECTD4 LAMA2 RNF213 NHS MACF1 TSHZ1 ANKRD12 TECPR1 | 1.87e-04 | 607 | 87 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_500 | 1.94e-04 | 495 | 87 | 9 | Facebase_RNAseq_e10.5_Olfactory Pit_500 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 4.56e-09 | 192 | 88 | 8 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | Adult-Epithelial-club_cell|Adult / Lineage, Cell type, age group and donor | 1.02e-07 | 190 | 88 | 7 | 756bff697d30aec56c0ebfca94295f084a15bf37 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-07 | 195 | 88 | 7 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-07 | 195 | 88 | 7 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.56e-06 | 180 | 88 | 6 | b509c7d6bdfba672065fb722874bdc68de72ba1c | |
| ToppCell | COVID-19-Epithelial_cells-AT2|COVID-19 / group, cell type (main and fine annotations) | 1.77e-06 | 184 | 88 | 6 | 369b82f793deab672204558ae4e112cfa5aa9ccc | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.83e-06 | 185 | 88 | 6 | 98b8ee42b89d97e4c9db01740e0c193503c68f2c | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 1.83e-06 | 185 | 88 | 6 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | IPF-Epithelial-ATII|World / Disease state, Lineage and Cell class | 1.88e-06 | 186 | 88 | 6 | 6a4ff2da0af0f5e590d9f9daa5b5e9ac8c868947 | |
| ToppCell | Adult-Epithelial-club_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.94e-06 | 187 | 88 | 6 | ee59d7d3de5879738ff0b9c3ea5e4847fb48cb86 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|World / Lineage, Cell type, age group and donor | 1.94e-06 | 187 | 88 | 6 | 81cc8435b2704a9a8287b3f54acaae0f11dd4ac7 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 2.07e-06 | 189 | 88 | 6 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 2.13e-06 | 190 | 88 | 6 | de5ef606a002f85c2e0e3a36c1f259d0b85a76ff | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 2.13e-06 | 190 | 88 | 6 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.13e-06 | 190 | 88 | 6 | cc17ab84a9328124f146951c06be3eff9650d9fd | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 2.20e-06 | 191 | 88 | 6 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.20e-06 | 191 | 88 | 6 | 23776c7302cead3881b39127398f3b3e0d27885e | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|World / Lineage, Cell type, age group and donor | 2.20e-06 | 191 | 88 | 6 | d3733c8c4bda70c4390e5601fdda6188a64be944 | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.20e-06 | 191 | 88 | 6 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 2.26e-06 | 192 | 88 | 6 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2|World / Lineage, Cell type, age group and donor | 2.26e-06 | 192 | 88 | 6 | 58c3737be7acce39fd2b91d70d6d7b2bbaa4f710 | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 2.26e-06 | 192 | 88 | 6 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | Epithelial-club_cell|World / Lineage, Cell type, age group and donor | 2.33e-06 | 193 | 88 | 6 | 2bdd09004fa433550958ec42ba4b06271a4aaf7c | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-Secretory/RAS|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.40e-06 | 194 | 88 | 6 | 0cd4363627acd419e00d6d32f6dce10430aa6487 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-Secretory/RAS-RAS|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.40e-06 | 194 | 88 | 6 | a58841b34efe673671a9a059238e044a7254b279 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.40e-06 | 194 | 88 | 6 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.48e-06 | 195 | 88 | 6 | 6477e6e7be5bd8eb99119a12ae16334ccddecd43 | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG|World / Primary Cells by Cluster | 2.63e-06 | 197 | 88 | 6 | 61749ccafeb938c310cff1de5ff924a1c794325a | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG-25|World / Primary Cells by Cluster | 2.63e-06 | 197 | 88 | 6 | 9d4ffa3680f92c91d0a081f9a8ec5ebfec6bdcf6 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.70e-06 | 198 | 88 | 6 | af399569c718f5fd971d73a7926768c9311002a3 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.70e-06 | 198 | 88 | 6 | 5fc25b008a4d8d6bec83923a16f64dd9e1ff1f2d | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 2.70e-06 | 198 | 88 | 6 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.70e-06 | 198 | 88 | 6 | 2e2a4e1756bba6f4fbe529559a97d2993c890b4b | |
| ToppCell | Bronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.78e-06 | 199 | 88 | 6 | 5f7da3eab58ace6cddb3179a415cd839d5767958 | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.78e-06 | 199 | 88 | 6 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 | |
| ToppCell | facs-Brain_Myeloid-Cortex-3m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-05 | 153 | 88 | 5 | 0ef7c45cdd854c79e527006034029767f8e108b2 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.75e-05 | 162 | 88 | 5 | 5c9bc3c3857a99d8a3caf359a7eb279ce9cc1c81 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L4|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.80e-05 | 163 | 88 | 5 | 1e8ab00ecc2d2ba35aa6745c0ed38663e26312e8 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L4-L4_IT_VISp_Rspo1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.80e-05 | 163 | 88 | 5 | 431221a41d396b09170476179590eaf8a55266d8 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.97e-05 | 166 | 88 | 5 | c20479fe7a4306320d7f26e78bf956225f00f35a | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.21e-05 | 170 | 88 | 5 | a2c738e441ced90eeeb1fcc6ca3269b918aaa298 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.27e-05 | 171 | 88 | 5 | 15cb4670ff4234ac46aea8a5911138d6913c4482 | |
| ToppCell | Adult-Epithelial-club_cell-D122|Adult / Lineage, Cell type, age group and donor | 2.75e-05 | 178 | 88 | 5 | 35a2e3ba98b6f857dbb79cf8ddb4846ddcda6c17 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.83e-05 | 179 | 88 | 5 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.83e-05 | 179 | 88 | 5 | cb38b54261a7af5ee3347e64c8aa880a77ed0763 | |
| ToppCell | P07-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.22e-05 | 184 | 88 | 5 | 01257e5c12e38b849fd3d9496c43ded666249ba5 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Adult / Lineage, Cell type, age group and donor | 3.31e-05 | 185 | 88 | 5 | 673f0c688ae6984bc8027df2da335787924f4137 | |
| ToppCell | IPF-Epithelial-ATII|IPF / Disease state, Lineage and Cell class | 3.31e-05 | 185 | 88 | 5 | 563b4e6d92bb5d77a3829556116a8e99aebac615 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.31e-05 | 185 | 88 | 5 | f98af3146ec2f44c30d31a662fb9c4fa3ca4f706 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.31e-05 | 185 | 88 | 5 | 03f64a7132b13a01ba47187e0e15c13ac88f7cb2 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.40e-05 | 186 | 88 | 5 | 2ea5ff14861e5f91d0e6a5767c403a24045d715c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.40e-05 | 186 | 88 | 5 | b87acc80b7baa41681e4ed11d5537b9fbf5832f5 | |
| ToppCell | 10x5'-Lung-Lymphocytic_Invariant-Inducer-like-ILC3|Lung / Manually curated celltypes from each tissue | 3.48e-05 | 187 | 88 | 5 | 0e7aa481effdd8c2fbdf8b65852821dec2d92cde | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 3.57e-05 | 188 | 88 | 5 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | 3.57e-05 | 188 | 88 | 5 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 | |
| ToppCell | COPD-Epithelial-ATII|COPD / Disease state, Lineage and Cell class | 3.57e-05 | 188 | 88 | 5 | eb6d79d733b53f64ca615bb777c64ed456866549 | |
| ToppCell | Control-Epithelial_cells|Control / group, cell type (main and fine annotations) | 3.57e-05 | 188 | 88 | 5 | 707ebf76cc6fb600b2f07793cf4ea9482c0de79d | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 3.66e-05 | 189 | 88 | 5 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.76e-05 | 190 | 88 | 5 | 8aea807a2bcf0b653b4de6202b6ecb0f0683cc2e | |
| ToppCell | COVID-19-lung-AT2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.76e-05 | 190 | 88 | 5 | 27a1a86620fe9b5ee930d388b32352206485e6d0 | |
| ToppCell | IPF-Epithelial-Goblet|IPF / Disease state, Lineage and Cell class | 3.76e-05 | 190 | 88 | 5 | e41dd5a997ad9952810ffecb57737c03ea1d88b3 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.85e-05 | 191 | 88 | 5 | a0332a4ef629510fb313ec119195c44a3f704a80 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 3.85e-05 | 191 | 88 | 5 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | COVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type | 3.85e-05 | 191 | 88 | 5 | 276455a64c2c3503d5048615762eb2ee37f0ac70 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.85e-05 | 191 | 88 | 5 | ca5669bd6f4a17471acae3eb229f845cc2e08efa | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.85e-05 | 191 | 88 | 5 | 27f23c2254b610abac1a88d0fecff305addde9da | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | 3.95e-05 | 192 | 88 | 5 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 3.95e-05 | 192 | 88 | 5 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.95e-05 | 192 | 88 | 5 | cc9911e182a289779a2612bc213daae5607689e7 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D122|Adult / Lineage, Cell type, age group and donor | 3.95e-05 | 192 | 88 | 5 | 06013a07e3a873b1d1c0451643c528593ac32a9c | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.95e-05 | 192 | 88 | 5 | fb2f0e897228f808d9ff734ad05e9b49dc38fa50 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.05e-05 | 193 | 88 | 5 | fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.05e-05 | 193 | 88 | 5 | 82e8a4c40299ffcdfd5a0da711bb9de6fb8a2eaa | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.05e-05 | 193 | 88 | 5 | 3866667dd221612589ae50f5c52f73a183a49ce6 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_OPC-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.05e-05 | 193 | 88 | 5 | efa91167dc7a59bf32addf90ffb7bf070b2a0151 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.05e-05 | 193 | 88 | 5 | f3cc7cfdbc164a4ed42f87647111522b7d393bcb | |
| ToppCell | Fetal_29-31_weeks-Epithelial|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.05e-05 | 193 | 88 | 5 | a0ca3231992f14abcf1a6129573bace320e89d2a | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Goblet|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.15e-05 | 194 | 88 | 5 | e0228f593c3493175962a4817500d4337ddc4e88 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.15e-05 | 194 | 88 | 5 | 7002937e8903e037332a215d00fbc7c7843b33f2 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.15e-05 | 194 | 88 | 5 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.15e-05 | 194 | 88 | 5 | 5eaaa81f4b2535f983c424aaef00077089526a5c | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 4.15e-05 | 194 | 88 | 5 | 89812fb164065041357bb37a3c2d87028ec3de4e | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 4.15e-05 | 194 | 88 | 5 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 4.25e-05 | 195 | 88 | 5 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.25e-05 | 195 | 88 | 5 | dccc32fcf772e2504de7f663ef0a5bd8e23e92fc | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.25e-05 | 195 | 88 | 5 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.25e-05 | 195 | 88 | 5 | e7230a849ea31e6eef9bc6f5468938499450582d | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.36e-05 | 196 | 88 | 5 | eea66711a16134f86e6c533a5a837ff2e0d7ca7f | |
| ToppCell | Control-Control-Lymphocyte-T/NK-NK_activated|Control / Disease, condition lineage and cell class | 4.57e-05 | 198 | 88 | 5 | 76d5fe4e5bbe6c73a6ca409b80b5c3924e07cab7 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.57e-05 | 198 | 88 | 5 | f948391296c261c473d339069a6d0f20ccd6f38f | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Club|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.57e-05 | 198 | 88 | 5 | 1408e02e053ad3406229bfe8189da03be6366e81 | |
| ToppCell | Non-neuronal-Dividing-Radial_Glia-vRG-20|World / Primary Cells by Cluster | 4.57e-05 | 198 | 88 | 5 | bce0bc1e3f2257e0f42a1fa6e5b57cf71e4514ba | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.68e-05 | 199 | 88 | 5 | 725610310e5c5fd7120c0be9acb55bf152026ddd | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.79e-05 | 200 | 88 | 5 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Parenchyma_COVID-19-Endothelial-TX-Artery|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 4.79e-05 | 200 | 88 | 5 | 34b279804475ea58fbb052b96f44128c082627a9 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Artery|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.79e-05 | 200 | 88 | 5 | 8552cc7a439449b30b59760c3e8667217b9852b5 | |
| ToppCell | Tracheal|World / Cell types per location group and 10X technology with lineage, and cell group designations | 4.79e-05 | 200 | 88 | 5 | 682960e28542a3d6c119047cd0131941932cfdea | |
| ToppCell | Tracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.79e-05 | 200 | 88 | 5 | d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Mucous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.79e-05 | 200 | 88 | 5 | ed093626a9cac7531a2bf02f6e345c5e84b8c060 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.79e-05 | 200 | 88 | 5 | 0eb9ad8c0373bcc62029ec21c590ed03aaacd039 | |
| Drug | Proglumide [6620-60-6]; Down 200; 12uM; MCF7; HT_HG-U133A | 1.04e-05 | 194 | 88 | 7 | 3861_DN | |
| Drug | Oxethazaine [126-27-2]; Up 200; 8.6uM; PC3; HG-U133A | 1.07e-05 | 195 | 88 | 7 | 1903_UP | |
| Drug | 15(S)-15-methyl Prostaglandin E2; Down 200; 10uM; MCF7; HT_HG-U133A | 1.18e-05 | 198 | 88 | 7 | 7489_DN | |
| Drug | Iopamidol [60166-93-0]; Down 200; 5.2uM; MCF7; HT_HG-U133A | 1.18e-05 | 198 | 88 | 7 | 7189_DN | |
| Drug | Anisomycin [22862-76-6]; Down 200; 15uM; PC3; HT_HG-U133A | 8.78e-05 | 187 | 88 | 6 | 6764_DN | |
| Drug | Fenoprofen calcium salt dihydrate [53746-45-5]; Up 200; 7.2uM; PC3; HT_HG-U133A | 9.59e-05 | 190 | 88 | 6 | 4274_UP | |
| Drug | Lasalocid sodium salt [25999-20-6]; Up 200; 6.6uM; HL60; HT_HG-U133A | 1.04e-04 | 193 | 88 | 6 | 3021_UP | |
| Drug | H-89, Dihydrochloride; Up 200; 0.5uM; PC3; HT_HG-U133A | 1.07e-04 | 194 | 88 | 6 | 6921_UP | |
| Drug | Hesperetin [520-33-2]; Down 200; 13.2uM; PC3; HG-U133A | 1.07e-04 | 194 | 88 | 6 | 1947_DN | |
| Drug | Pindolol [13523-86-9]; Up 200; 16.2uM; MCF7; HT_HG-U133A | 1.11e-04 | 195 | 88 | 6 | 6834_UP | |
| Drug | Nomegestrol acetate [58652-20-3]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 1.14e-04 | 196 | 88 | 6 | 5461_DN | |
| Drug | rosiglitazone; Down 200; 10uM; HL60; HT_HG-U133A | 1.14e-04 | 196 | 88 | 6 | 1174_DN | |
| Drug | Chelidonine monohydrate (+) [476-32-4]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 1.14e-04 | 196 | 88 | 6 | 6236_DN | |
| Drug | 3-Acetylcoumarin [3949-36-8]; Down 200; 21.2uM; MCF7; HT_HG-U133A | 1.14e-04 | 196 | 88 | 6 | 5624_DN | |
| Drug | L(-)-vesamicol hydrochloride [112709-59-8]; Down 200; 13.6uM; HL60; HT_HG-U133A | 1.14e-04 | 196 | 88 | 6 | 3118_DN | |
| Drug | Sulfamonomethoxine [1220-83-3]; Up 200; 14.2uM; HL60; HT_HG-U133A | 1.14e-04 | 196 | 88 | 6 | 2742_UP | |
| Drug | Mevalonic-D, L acid lactone [674-26-0]; Up 200; 30.8uM; MCF7; HT_HG-U133A | 1.17e-04 | 197 | 88 | 6 | 3459_UP | |
| Drug | Phenethicillin potassium salt [132-93-4]; Down 200; 10uM; MCF7; HT_HG-U133A | 1.17e-04 | 197 | 88 | 6 | 6105_DN | |
| Drug | Roxithromycin [80214-83-1]; Up 200; 4.8uM; HL60; HT_HG-U133A | 1.17e-04 | 197 | 88 | 6 | 2992_UP | |
| Drug | Mafenide hydrochloride [138-37-4]; Up 200; 18uM; MCF7; HT_HG-U133A | 1.17e-04 | 197 | 88 | 6 | 5499_UP | |
| Drug | LY 294002; Down 200; 10uM; MCF7; HT_HG-U133A | 1.17e-04 | 197 | 88 | 6 | 5236_DN | |
| Drug | Pivampicillin [33817-20-8]; Up 200; 8.6uM; HL60; HT_HG-U133A | 1.17e-04 | 197 | 88 | 6 | 2945_UP | |
| Drug | Terbutaline hemisulfate [23031-32-5]; Down 200; 7.2uM; MCF7; HT_HG-U133A | 1.17e-04 | 197 | 88 | 6 | 6240_DN | |
| Drug | Amprolium hydrochloride [137-88-2]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 1.20e-04 | 198 | 88 | 6 | 4825_DN | |
| Drug | retinoic acid; Down 200; 1uM; PC3; HT_HG-U133A | 1.20e-04 | 198 | 88 | 6 | 4435_DN | |
| Drug | Bemegride [64-65-3]; Down 200; 25.8uM; PC3; HT_HG-U133A | 1.20e-04 | 198 | 88 | 6 | 6668_DN | |
| Drug | Cotinine (-) [486-56-6]; Down 200; 22.6uM; MCF7; HT_HG-U133A | 1.20e-04 | 198 | 88 | 6 | 5246_DN | |
| Drug | Dimethisoquin hydrochloride [2773-92-4]; Down 200; 13uM; MCF7; HT_HG-U133A | 1.20e-04 | 198 | 88 | 6 | 4791_DN | |
| Drug | Tyloxapol [25301-02-4]; Up 200; 4uM; MCF7; HT_HG-U133A | 1.20e-04 | 198 | 88 | 6 | 5672_UP | |
| Drug | Bergenin monohydrate [477-90-7]; Up 200; 11.6uM; PC3; HT_HG-U133A | 1.20e-04 | 198 | 88 | 6 | 5870_UP | |
| Drug | Tiratricol, 3,3',5-triiodothyroacetic acid [51-24-1]; Up 200; 6.4uM; MCF7; HT_HG-U133A | 1.20e-04 | 198 | 88 | 6 | 7011_UP | |
| Drug | Hexylcaine hydrochloride [532-76-3]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 1.24e-04 | 199 | 88 | 6 | 6244_DN | |
| Drug | Proparacaine hydrochloride [5875-06-9]; Up 200; 12uM; MCF7; HT_HG-U133A | 1.24e-04 | 199 | 88 | 6 | 6492_UP | |
| Drug | Isoxicam [34552-84-6]; Up 200; 12uM; MCF7; HT_HG-U133A | 1.24e-04 | 199 | 88 | 6 | 7028_UP | |
| Drug | Metolazone [17560-51-9]; Up 200; 11uM; PC3; HG-U133A | 1.24e-04 | 199 | 88 | 6 | 1932_UP | |
| Drug | Gelsemine [509-15-9]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 1.24e-04 | 199 | 88 | 6 | 4177_UP | |
| Drug | Disopyramide [3737-09-5]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 1.24e-04 | 199 | 88 | 6 | 7439_UP | |
| Drug | Minocycline hydrochloride [13614-98-7]; Down 200; 8uM; MCF7; HT_HG-U133A | 1.24e-04 | 199 | 88 | 6 | 7436_DN | |
| Disease | coronary artery disease | ZHX3 SHROOM3 MIA3 EHBP1L1 MAST4 FARP1 HECTD4 FMN2 RNF213 INO80 SAP130 WNK2 GGCX RAI1 | 7.59e-06 | 1194 | 85 | 14 | EFO_0001645 |
| Disease | Malignant neoplasm of breast | AKAP6 BOC KMT2D FARP1 SRC NUP98 LAMA2 NCOA1 NHS MACF1 ZNF318 GGA1 PRRC2A | 1.19e-05 | 1074 | 85 | 13 | C0006142 |
| Disease | reaction time measurement | AKAP6 KMT2D KIAA1549L FARP1 HECTD4 NCOA1 TSHZ1 RIMS1 RERE RAI1 | 1.98e-05 | 658 | 85 | 10 | EFO_0008393 |
| Disease | prostate carcinoma | CCDC88C SHROOM3 SALL3 MAST4 TRIO PPP1R13B RNF213 TSHZ1 SIX1 SOX13 GGCX | 4.98e-05 | 891 | 85 | 11 | EFO_0001663 |
| Disease | neuroimaging measurement | CCDC88C ZHX3 ZNF469 SHROOM3 MAST4 LAMA2 NINL MACF1 BCAN RERE WNK2 RAI1 | 5.53e-05 | 1069 | 85 | 12 | EFO_0004346 |
| Disease | cortical thickness | AKAP6 ZHX3 ZNF469 SHROOM3 MAST4 LAMA2 FMN2 MACF1 ZNF318 RERE WNK2 | 3.48e-04 | 1113 | 85 | 11 | EFO_0004840 |
| Disease | autism spectrum disorder, schizophrenia | 3.71e-04 | 327 | 85 | 6 | EFO_0003756, MONDO_0005090 | |
| Disease | angina pectoris | 4.77e-04 | 125 | 85 | 4 | EFO_0003913 | |
| Disease | colon carcinoma (is_marker_for) | 6.27e-04 | 13 | 85 | 2 | DOID:1520 (is_marker_for) | |
| Disease | basophil measurement | 7.01e-04 | 60 | 85 | 3 | EFO_0803539 | |
| Disease | Headache | 8.47e-04 | 64 | 85 | 3 | HP_0002315 | |
| Disease | Craniofacial Abnormalities | 1.09e-03 | 156 | 85 | 4 | C0376634 | |
| Disease | cortical surface area measurement | CCDC88C HOXB1 ZHX3 ZNF469 SHROOM3 MAST4 LAMA2 MACF1 RERE PRRC2A WNK2 | 1.64e-03 | 1345 | 85 | 11 | EFO_0010736 |
| Disease | sleep duration, low density lipoprotein cholesterol measurement | 2.33e-03 | 91 | 85 | 3 | EFO_0004611, EFO_0005271 | |
| Disease | refractive error, age at onset, Myopia | 2.38e-03 | 193 | 85 | 4 | EFO_0004847, HP_0000545, MONDO_0004892 | |
| Disease | blood chromium measurement | 2.55e-03 | 26 | 85 | 2 | EFO_0007579 | |
| Disease | obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia, anorexia nervosa | 2.70e-03 | 200 | 85 | 4 | EFO_0003756, EFO_0003761, EFO_0003888, EFO_0004242, EFO_0004895, MONDO_0004985, MONDO_0005090, MONDO_0005351 | |
| Disease | Agents acting on the renin-angiotensin system use measurement | 2.86e-03 | 335 | 85 | 5 | EFO_0009931 | |
| Disease | DNA methylation | 2.87e-03 | 656 | 85 | 7 | GO_0006306 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| APASQEPSPAASAEA | 541 | O00429 | |
| PAPNSESVASDRTQP | 381 | Q7LC44 | |
| PTSSDCPFQAPNVSS | 686 | Q8NFM4 | |
| SAPAEANTPQDATSA | 1466 | O60306 | |
| RDNSPDSTPNHPSQT | 146 | Q6UB98 | |
| AQSEASPVASPDPQR | 1116 | Q8NB25 | |
| APSSDANDNELPSPE | 786 | Q96KQ4 | |
| QSPPSQSPDSDLRAS | 116 | Q09MP3 | |
| ASSPSNPAALPVASD | 1106 | Q7Z5J4 | |
| DPASSAPQSRATNSP | 1386 | Q9ULG1 | |
| PRSSASAAPSQAEPA | 211 | Q9BRQ5 | |
| PAPPDQLNTSSAESE | 21 | P30203 | |
| SAQPSAIPEASNPAS | 356 | Q96GW7 | |
| AIPEASNPASNPASD | 361 | Q96GW7 | |
| RDDPFTQPDQSTPSS | 296 | P98082 | |
| APQAPVALTDPNASA | 481 | P52948 | |
| PTNDTAANSASPPAE | 331 | P25090 | |
| AANSASPPAETELQA | 336 | P25090 | |
| ADNPTDDTATQPNFP | 51 | Q8NDZ0 | |
| QLESSDPASPAASQP | 1436 | Q9P219 | |
| STPNPDTQASASPDP | 121 | Q6H9L7 | |
| SSEQASAQSEPSPAP | 156 | P20719 | |
| APSPNSDDFNRESPS | 196 | Q99081 | |
| ASPSNAEDTSPAPVS | 236 | Q8N3D4 | |
| ASPAAAVSNLEEPAS | 1281 | O94854 | |
| QSSDATEPPAPALAQ | 386 | Q9UJY5 | |
| EAPAAASTQPSRPQE | 936 | Q96RT7 | |
| PNPASTSADTNDPVF | 3051 | P24043 | |
| AAQPDSSSAQAPGPS | 136 | P13985 | |
| PSLEQAPAPSTAASQ | 1791 | Q6ZVL6 | |
| SDVSNPPNPTAVAAD | 341 | A2A3K4 | |
| PSLNSEQEDPSDPAS | 1456 | Q9Y4D8 | |
| HSDPSRNQPSPDAAA | 746 | Q6ZSS7 | |
| EPSAQENPFTAPSAK | 521 | Q5TIA1 | |
| PLSTAAASSQDAAPP | 221 | Q86UR5 | |
| AASSQDAAPPSAPPD | 226 | Q86UR5 | |
| DAPEAAAQSPCSVPS | 1011 | O14559 | |
| SAPTSFPPSSAQAVD | 26 | P14653 | |
| DDPGASPQSSSQPDH | 586 | Q9BWV1 | |
| SSPPDNKSPDEATAA | 871 | Q9Y4F1 | |
| DSAPTAQPDVPADAS | 161 | A1L170 | |
| TDFSSASAPDQSAPP | 91 | Q8NI60 | |
| APADESQASVPQPAS | 566 | Q92771 | |
| SADKPASLPPASQAS | 1541 | Q9BTC0 | |
| PHSSSDAAQAPAEQP | 31 | P29372 | |
| PAEQPHSSSDAAQAP | 41 | P29372 | |
| TPATAPSATSPAQEE | 441 | Q04637 | |
| NSPQDSPRNFSPSAS | 256 | O15021 | |
| ASTSQPDPSPDRSAN | 366 | P20749 | |
| SLPAAQPAAKDSPSS | 306 | Q9NZ56 | |
| PSQPNASTERPSTDS | 71 | Q9Y2C5 | |
| APAPQSAASSQPQSA | 326 | Q9BXA9 | |
| VNSASSSNPPAEVDP | 381 | Q9BY77 | |
| RTANENNTPSPAEPT | 291 | Q3MIW9 | |
| DSAVASDNSPVTQPA | 281 | Q9UBD0 | |
| ANSNIPSTTPSPDSE | 381 | A4D263 | |
| AFPASQTPSKPASAD | 31 | P12931 | |
| SSSPAQSEPPASAEA | 631 | Q7LBE3 | |
| DEPPPASQSTSQDCS | 1886 | Q5JRA6 | |
| TPNDFSEAPSSPSAQ | 541 | Q6T4R5 | |
| SEAPSSPSAQDHQPT | 546 | Q6T4R5 | |
| PASTSPFSQLAANPE | 1181 | Q15788 | |
| ANALPPQDQASTPSS | 11 | A5D8V7 | |
| EAPTPPASETQAQDS | 126 | Q9ULN7 | |
| KSSDASTAQPPESQP | 96 | P48634 | |
| ASASFNSTDPSPEEP | 731 | Q8TF72 | |
| SEEEFSPPQSPDQNS | 216 | Q15475 | |
| TSPSIPSPQDNESDS | 711 | Q9P2R6 | |
| EASPQASSAEVNASP | 321 | O94864 | |
| QAQDTEATQSPAPAP | 881 | Q9Y2I6 | |
| FSSAPPNESAVPSEA | 2171 | Q13023 | |
| PAQAPTSDSPVAEDA | 51 | P55789 | |
| DPPASAPPDSSSNSA | 491 | Q15642 | |
| PPAAPIADSENNNST | 26 | Q63HN8 | |
| PARASQDSADPQAPA | 51 | Q9UN79 | |
| PQHDSPAPEASALSQ | 181 | O14709 | |
| AASSDQLRDNSPPPA | 976 | Q9UDY2 | |
| PSNTDSSHSNPPESN | 736 | P38435 | |
| PAQASPAQASPARAS | 76 | Q9BYE2 | |
| VPSNASVNASSADEP | 31 | Q8WZ71 | |
| SSSQEQEPSAPPEAH | 1146 | Q7Z6L1 | |
| ANPISNPFSAAPAAT | 631 | Q9H0E3 | |
| PQPSAEAAAAPSLAN | 1946 | Q6ZS81 | |
| PQESFPEENASSPFT | 356 | O14795 | |
| PSNPDGAATPDSASA | 3251 | Q96JG9 | |
| RPNSPESTSSDASQP | 36 | P58753 | |
| DDVTETPSNPNSPSA | 91 | Q8NET8 | |
| SAESAQSKQPPDSAP | 1371 | Q9Y3S1 | |
| LPPEASAASSEAAQN | 41 | Q9H4I2 | |
| ASAQPAAIPSDETAP | 1506 | Q5VUA4 | |
| NDASQKESSAPTPTP | 146 | Q6ZSZ6 | |
| SNDASPPASVASLQP | 1741 | O75962 | |
| DPFSRVPASPQSQSS | 2406 | O14686 | |
| SPSSINQNFPASTDP | 2086 | Q5VU43 | |
| IAASPSSALSPNPEA | 436 | Q8NFW9 |